Amyloid: From Starch to Finish.
Amyloid: From Starch to Finish.
复制标题
淀粉样蛋白:从淀粉到完成。
DOI:
10.1016/j.biopsych.2020.02.1182
复制
发表时间:
2020
影响因子:
10.6
通讯作者:
Mecca,AdamP
中科院分区:
文献类型:
--
作者:
Krystal,HannahL;Ross,DavidA;Mecca,AdamP
In 1639, Nicholas Fontanus examined an unusual specimen: a recently deceased young man whose abdomen sloshed with excess fluid and whose skin had turned the deep yellow of severe jaundice. During the autopsy, Fontanus found large white stones in his spleen. In 1722, Jeremiah Wainewright autopsied a patient whose swollen neck suggested thyroid disease, but an unexpected finding challenged the diagnosis: tucked underneath the patient’s ribcage, his liver had swelled to between two and three times its normal size to make room for a mysterious, clay-colored substance. In 1789, Antoine Portal opened the body of a deceased elderly woman to discover a liver with the texture of rendered fat.Soon, the terms “lardaceous” and “waxy” began appearing in medical textbooks to describe livers and kidneys suffering from this strange malady. Eventually, Rudolph Virchow, chair of pathologic anatomy at the University of Bavaria in Würzburg, weighed in. Virchow, a scientist most famous for his work on cell division, disapproved of both descriptors. He believed that the strange substance was starch, a linear sugar molecule typically found in plants. But other researchers disagreed, thinking that a more accurate comparison might be cellulose, starch’s fibrous, indigestible cousin. So Virchow forced the debate. In 1854, he applied a relatively new term–one created in 1838 by German botanist Matthias Schleiden to describe a normal, starchy plant component–to the strange material depositing in human tissues (1). The mysterious substance still defied explanation, but at last received a unifying name: amyloid.